Results 11 to 20 of about 1,311,488 (249)

Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery

open access: yesInternational Journal of Nanomedicine, 2013
Sai-Nan He,1 Yun-Long Li,1,2 Jing-Jing Yan,2 Wei Zhang,2 Yong-Zhong Du,2 He-Yong Yu,1 Fu-Qiang Hu,2 Hong Yuan21Women’s Hospital, 2College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of ...
He SN   +6 more
doaj   +1 more source

Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation

open access: yesInternational Journal of Nanomedicine, 2014
Xingwang Zhang,* Guijiang Chen,* Tianpeng Zhang, Zhiguo Ma, Baojian WuDivision of Pharmaceutics, College of Pharmacy, Jinan University, Guangzhou, People’s Republic of China*These authors contributed equally to this workAbstract ...
Zhang XW   +4 more
doaj   +1 more source

Use of magnetic nanoparticles to enhance biodesulfurization [PDF]

open access: yes, 2008
Biodesulfurization (BDS) is an alternative to hydrodesulfurization (HDS) as a method to remove sulfur from crude oil. Dibenzothiophene (DBT) was chosen as a model compound for the forms of thiophenic sulfur found in fossil fuels; up to 70% of the sulfur ...
Ansari, Farahnaz
core   +7 more sources

Lipid Nanoparticles for the Posterior Eye Segment

open access: yesPharmaceutics, 2021
This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for pathologies affecting the posterior ocular segment. Eye anatomy and the most
Lorena Bonilla   +8 more
doaj   +1 more source

Preclinical Evaluation of Lipid-Based Nanosystems

open access: yesPharmaceutics, 2021
The use of lipid-based nanosystems, including lipid nanoparticles (solid lipid nanoparticles—SLN, and nanostructured lipid carriers—NLC), nanoemulsions, and liposomes, among others, is widespread [...]
Ana Catarina Silva   +1 more
doaj   +1 more source

Lipid Polymeric Hybrid Nanoparticles: Formulation Techniques and Effects on Glioblastoma [PDF]

open access: yesPharmaceutical Sciences, 2022
In the pharmaceutical industry, liposomes and polymeric nanoparticles are the two most commonly studied delivery vehicles. A new technique uses lipid-polymeric hybrid nanoparticles (LPHNPs) with a polymeric core, and a shell made up of lipid-lipid-PEG ...
Yudhishtir Singh Baghel   +1 more
doaj   +1 more source

Review article on nanoemulsions and nanostructured lipid carriers [PDF]

open access: yesRecords of Pharmaceutical & Biomedical Sciences, 2018
Lipid nanoparticles, including nanoemulsions (NEs) and nanostructured lipid carriers (NLCs) are colloidal carriers with a lipid matrix that is solid at body temperature.
mamdouh ghorab   +3 more
doaj   +1 more source

Editorial—Current Insights on Lipid-Based Nanosystems

open access: yesPharmaceuticals, 2022
Lipid-based nanosystems, including solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), cationic lipid nanoparticles, nanoemulsions and liposomes, have been extensively studied to improve drug delivery through different administration
Ana Catarina Silva   +2 more
doaj   +1 more source

Use of Microfluidics to Prepare Lipid-Based Nanocarriers

open access: yesPharmaceutics, 2023
Lipid-based nanoparticles (LBNPs) are an important tool for the delivery of a diverse set of drug cargoes, including small molecules, oligonucleotides, and proteins and peptides. Despite their development over the past several decades, this technology is
Alicia Vogelaar   +4 more
doaj   +1 more source

Effect of size, shape, and surface modification on cytotoxicity of gold nanoparticles to human Hep-2 and canine MDCK cells [PDF]

open access: yes, 2012
There have been increasing interests in applying gold nanoparticles in biological research, drug delivery, and therapy. As the interaction of gold nanoparticles with cells relies on properties of nanoparticles, the cytotoxicity is complex and still under
Li, Wenqin   +4 more
core   +4 more sources

Home - About - Disclaimer - Privacy